United Therapeutics (UTHR) net assets (shareholders' equity)

Net assets · fiscal 2025
$7.10B

United Therapeutics (UTHR) had net assets of $7.10B at the end of fiscal 2025 (December 31, 2025). That is 10.1% higher than the $6.44B of fiscal 2024. Figures as of 19 Nov 2026, 02:58 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$7.10B
Change on fiscal 2024
+10.1%
Growth, 5 years
+15.9% a year
Growth, 10 years
+16.1% a year
Highest on record
$7.10Bfiscal 2025
Lowest on record
$555.33Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

United Therapeutics net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 15.9% a year; over ten years the rate was 16.1% a year. Across the 18 fiscal years on record (2008–2025), the highest was $7.10B in fiscal 2025 and the lowest $555.33M in fiscal 2008.

History · 18 fiscal years

Net assets by fiscal year

United Therapeutics net assets (shareholders' equity), year by year

United Therapeutics (UTHR) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$7.10B 10.1% up
2024$6.44B 7.7% up
2023$5.98B 24.8% up
2022$4.80B 21.2% up
2021$3.96B 16.6% up
2020$3.40B 22.1% up
2019$2.78B 0.3% down
2018$2.79B 32.7% up
2017$2.10B 13.5% up
2016$1.85B 16.5% up
2015$1.59B 27.9% up
2014$1.24B 1.3% down
2013$1.26B 16.2% up
2012$1.08B 14.3% up
2011$948.49M 7.3% up
2010$883.89M 35.4% up
2009$653.01M 17.6% up
2008$555.33M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of United Therapeutics and comparable companies
CompanyNet assetsFiscal year
STERIS STE$7.18B2026
Insmed INSM$738.98M2025
United Therapeutics UTHR$7.10B2025
Incyte INCY$5.17B2025
Viatris VTRS$14.71B2025
Tenet Healthcare THC$4.22B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on UTHR

United Therapeutics, figure by figure

United Therapeutics (UTHR) overview: price, valuation and scorecardAll health care companies by market value

United Therapeutics net assets (shareholders' equity): questions and answers

What are United Therapeutics's net assets?

United Therapeutics (UTHR) had net assets of $7.10B at the end of fiscal 2025 (December 31, 2025). That is 10.1% higher than the $6.44B of fiscal 2024.

What is the growth rate of United Therapeutics's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 15.9% a year; over ten years the rate was 16.1% a year.

What are the highest and lowest net assets figures on record for United Therapeutics?

Across the 18 fiscal years on record (2008–2025), the highest was $7.10B in fiscal 2025 and the lowest $555.33M in fiscal 2008.

How is United Therapeutics's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For United Therapeutics it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “United Therapeutics (UTHR) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/UTHR/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.